C
Cheryl Gillett
Researcher at King's College London
Publications - 146
Citations - 12223
Cheryl Gillett is an academic researcher from King's College London. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 52, co-authored 136 publications receiving 11077 citations. Previous affiliations of Cheryl Gillett include Guy's and St Thomas' NHS Foundation Trust & Guy's Hospital.
Papers
More filters
Proceedings ArticleDOI
Abstract B046: Therapeutic targeting of integrin αvβ6 in high-risk breast cancer
Kate Moore,Gareth J. Thomas,Stephen W. Duffy,Jane Warwick,Rhian Gabe,Patrick Chou,Ian O. Ellis,Andrew R. Green,Syed Haider,Kellie Brouilette,Antonio Saha,Sabari Vallath,R L Bowen,Claudia Chelala,Diana Eccles,William J. Tapper,Alastair M. Thompson,P Quinlan,Lee B. Jordan,Cheryl Gillett,Adam R. Brentnall,Shelia M Violette,Paul H. Weinreb,Jane Kendrew,Simon T. Barry,Ian R. Hart,Louise Jones,John Marshall +27 more
TL;DR: Targeting αvβ6 with 264RAD alone or in combination with trastuzumab may provide a novel therapy for treating high-risk and trastzumab-resistant breast cancer patients, giving hope to the 70% of women treated who have, or develop, resistance.
Journal ArticleDOI
Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy–Resistant Early Breast Cancers
Patrycja Gazinska,Charlotte K. Milton,Jacopo Iacovacci,Joseph Ward,Richard Buus,Thanussuyah Alaguthurai,Rosalind Graham,Ayse U. Akarca,Esther H. Lips,Kalnisha Naidoo,Jelle Wesseling,Teresa Marafioti,Maggie C.U. Cheang,Cheryl Gillett,Yin Wu,Aadil A. Khan,Alan Melcher,Roberto Salgado,Mitch Dowsett,Andrew Tutt,Ioannis Roxanis,Syed Haider,Sheeba Irshad +22 more
TL;DR: This study identifies several potential immunologic pathways in residual disease, which may be targeted to benefit high-risk patients and validated using expression profiling of cancer and immune-related genes.
Journal Article
Four genes by RT-PCR predicts distant relapse for women given adjuvant tamoxifen
Christine Desmedt,Sherene Loi,Benjamin Haibe-Kains,Anne Soree,Françoise Lallemand,V. Durbecq,Denis Larsimont,Andrew Tutt,Paul Ellis,Cheryl Gillett,K Ryder,Adrian L. Harris,Fatima Cardoso,Philippe Martiat,M.J. Piccart,Christos Sotiriou +15 more
Journal ArticleDOI
Expression of the c-erbB-4/her-4 growth factor receptor in breast cancer
Journal ArticleDOI
An alternative method of dissecting mastectomy specimens.
TL;DR: The value of slicing mastectomy specimens parallel to the skin surface is explored to see if this facilitates evaluation of disease and produces more uniform slices.